CLEVELAND and SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- Cell X Technologies, pioneers in automated cell processing solutions, and Aspen Neuroscience, Inc., dedicated to autologous regenerative medicine, ...
PD-L1 × TIGIT × LAG3 format enables simultaneous interrogation of three complementary checkpoint pathways within a single in vivo system ...
Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results